The Latest Breaking News from CMS

Analysts have provided the following ratings for CMS Energy (NYSE:CMS) within the last quarter:

The drug industry, patient advocates and congressional Republicans have all attacked federal officials’ decision to decline routine Medicare coverage for a controversial Alzheimer’s drug. They’ve gone as far as to accuse them of tacit racism, ageism and discrimination against the disabled — and hinted at a lawsuit — over the…

WASHINGTON — Advocates on both sides of a debate over dramatically restricting Medicare’s coverage of an expensive and controversial Alzheimer’s treatment are waging competing campaigns to influence a final decision in April.

Competing campaigns look to influence the debate over dramatically restricting coverage of a controversial treatment drug Aduhelm.

A group of states is renewing a challenge to President Joe Biden's requirement that millions of healthcare workers across the U.S. be vaccinated

  CMS Energy (NYSE:CMS) reported its Q4 earnings results on Thursday, February 3, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

CMS Energy (NYSE:CMS) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that CMS Energy will likely report an Earnings Per Share (EPS) of $0.44.

As COVID-19 cases rise again in nursing homes, a few states have begun requiring visitors to present proof that they’re not infected before entering facilities, stoking frustration and dismay among family members.

A medida que los casos de COVID-19 vuelven a aumentar en los hogares de adultos mayores, algunos estados han empezado a exigir a los visitantes pruebas negativas antes de entrar en las instalaciones, lo que ha reavivado la frustración y la inquietud entre los familiares.

Patti Poppe goes from CEO of CMS Energy to the California giant.

Enjoy building your website for free while utilizing dozens of videos to guide you as you go.